Stryker a global leader in medical technologies, announced that its OptaBlate basivertebral nerve ablation system (OptaBlate BVN) received 510(k) clearance from the U.S. Food and Drug Administration. OptaBlate BVNA is used in a targeted minimally invasive procedure providing long-lasting

Stryker ，一家全球领先的医疗技术公司，宣布其OptaBlate基椎神经消融系统（OptaBlate BVN）获得了美国食品药品监督管理局（FDA）的510(k)许可。OptaBlate BVNA用于针对性的微创手术，提供持久的效果。

vertebrogenic pain relief

椎源性疼痛缓解

. The addition of the OptaBlate BVN to Stryker's pain portfolio expands its advanced pain therapy solutions for patients and is an intersection of its two core competencies: radiofrequency ablation technology and vertebral access.

OptaBlate BVN的加入扩展了Stryker的疼痛治疗产品组合，为患者提供了更先进的疼痛治疗解决方案，这也是其两大核心竞争力——射频消融技术和椎体通路——的结合点。

OptaBlate BVN ablation in vertebral body

OptaBlate BVN 椎体消融术

OptaBlate BVN – generator and probes

OptaBlate BVN – 发生器和探针

'We often see patients with chronic low back pain who have tried multiple treatments—physical therapy, injections, medications—without lasting relief,' said Dr.

“我们经常看到慢性下背痛的患者，他们尝试了多种治疗方法——物理治疗、注射、药物——但都没有持久的缓解，”医生说。

Jad Khalil

贾德·哈利勒

, Spine Surgeon at Michigan Orthopaedic Surgeons. 'BVNA is a minimally invasive and innovative procedure that targets a key source of this pain, particularly in patients with specific MRI findings. Before BVNA, options for lasting relief were limited. For many, it offers meaningful improvement and can help avoid more aggressive treatments like surgery.'.

，密歇根骨科医生的脊柱外科医生。‘BVNA是一种微创且创新的手术，针对这种疼痛的一个关键来源，特别是对于具有特定MRI结果的患者。在BVNA之前，持久缓解的选项有限。对许多人来说，它提供了显著的改善，并可以帮助避免更具侵略性的治疗，如手术。’

Key features of the system include:

系统的主要特点包括：

Achieves at least a 1 cm lesion in

达到至少1厘米的病灶

7 minutes

7分钟

Steerable, dynamic curved introducer for

可操控的动态弯曲导入器

targeted performance

目标性能

Microinfusion technology, which keeps the zone hydrated, reducing impedance errors and preventing charring

微输注技术，保持区域水润，减少阻抗误差，防止烧焦

10-gauge access tools

10号规格的访问工具

'We have a long history in radiofrequency ablation, and we're relentlessly committed to delivering groundbreaking approaches to protect and promote quality of life,' said

“我们在射频消融领域有着悠久的历史，并且始终不渝地致力于提供开创性的方法来保护和提升生活质量，”

Kristen Berg

克里斯汀·伯格

, vice president and general manager of Stryker's Interventional Spine business. 'Our legacy providing solutions to reduce pain now continues with OptaBlate BVN, addressing the underserved population suffering from chronic vertebrogenic lumbar pain.'

，史赛克介入脊柱业务的副总裁兼总经理。“我们提供减痛方案的传统现在通过OptaBlate BVN得以延续，针对服务不足的慢性椎体源性腰痛患者群体。”

Stryker's Interventional Spine business will introduce OptaBlate BVN as part of its pain portfolio at the American Society of Pain & Neuroscience (ASPN) Annual Meeting,

史赛克的介入脊柱业务将在美国疼痛与神经科学学会 (ASPN) 年度会议上，作为其疼痛产品组合的一部分推出 OptaBlate BVN。

July 17-20

7月17日至20日

Miami, FL.

迈阿密，佛罗里达州。

(Booth #154).

（展位号154）。

About Stryker

关于Stryker

Stryker is a global leader in medical technologies and, together with its customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.

史赛克是医疗技术领域的全球领导者，我们与客户一起致力于改善医疗服务。我们在外科、神经技术和骨科领域提供创新的产品和服务，有助于改善患者和医疗效果。我们与世界各地的客户一起，每年影响超过1.5亿名患者。